EUVIMEDEUVIMED entdecken
Crossref

Novel Benzochromenes: Design, Synthesis, Cytotoxicity, Molecular Docking and Mechanistic Investigations

Fatma G Abdulrahman iD, Hamada S Abulkhair iD, Riham A Zidan, Asmaa I Alwakeel, Ahmed A Al-Karmalawy iD, Ebtehal M Husseiny iD

Future Medicinal Chemistry · 2024

DOI: 10.4155/fmc-2023-0198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Fatma G Abdulrahman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Al-Azhar University, Nasr City, 11754, Cairo, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

A novel series of fused benzochromenes with expected cytotoxicity and HIF-1α inhibition was identified. Materials & methods: A bioisosterism-aided approach was applied to design new benzochromenes and assess their cytotoxicity against three cancer cell lines. The probable mechanistic effect and the in silico docking and pharmacokinetic profiles of the most effective derivatives were evaluated.

Results

Compounds 3, 4, 5, 8 and 11 showed potent antiproliferative activity and excellent selectivity. Compound 8 showed significant HIF-1α inhibition with an IC50 value of 3.372 μM. It also enhanced apoptosis and arrested the HepG2 cell cycle at both the G0/G1 and S stages.

Conclusion

Compound 8 was identified as a new potential anticancer candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHumansCell Line, TumorMolecular Docking SimulationHep G2 CellsApoptosisDrug Screening Assays, AntitumorMolecular StructureCell ProliferationStructure-Activity RelationshipDrug Design

Stichwörter der Autor:innen

HIFHepG2apoptosisbenzochromenecell cyclechromenopyridinechromenopyrimidinecytotoxicity: cancersynthesis

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Pharmaceutical Organic Chemistry Department, Al-Azhar University, Nasr City, 11754, Cairo, Egypt.
  • Pharmaceutical Organic Chemistry Department, Al-Azhar University, Nasr City, 11884, Cairo, Egypt.
  • Pharmaceutical Chemistry Department, Horus University-Egypt, International Coastal Road, New Damietta, 34518, Egypt.
  • Department of Biochemistry, Al-Azhar University, Cairo, Egypt.
  • Department of Pharmacology & Toxicology, Al Azhar University, Cairo, Egypt.
  • Pharmaceutical Chemistry Department, Ahram Canadian University, Giza, 12566, Egypt.

ORCID-Profile: Fatma G Abdulrahman, Hamada S Abulkhair, Ahmed A Al-Karmalawy, Ebtehal M Husseiny

Zitieren

APA

Abdulrahman, F. G., Abulkhair, H. S., Zidan, R. A., Alwakeel, A. I., Al-Karmalawy, A. A., & Husseiny, E. M. (2024). Novel Benzochromenes: Design, Synthesis, Cytotoxicity, Molecular Docking and Mechanistic Investigations. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0198

Vancouver

Abdulrahman FG, Abulkhair HS, Zidan RA, Alwakeel AI, Al-Karmalawy AA, Husseiny EM. Novel Benzochromenes: Design, Synthesis, Cytotoxicity, Molecular Docking and Mechanistic Investigations. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0198

BibTeX
@article{Abdulrahman2024,
  author = {Abdulrahman, Fatma G and Abulkhair, Hamada S and Zidan, Riham A and Alwakeel, Asmaa I and Al-Karmalawy, Ahmed A and Husseiny, Ebtehal M},
  title = {Novel Benzochromenes: Design, Synthesis, Cytotoxicity, Molecular Docking and Mechanistic Investigations},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.4155/fmc-2023-0198}
}
Kostenlos starten →